Pro Mito Charger
Natural health product licensed in Canada
- Other names
- Mito Energy
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80088927
- Status
- Active licence
- Licence date
- 25 October 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium | 250 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 8.33 mg | Not calculated |
| Beta vulgaris Source : Racine Potency : 0 2-4% Nitrate | 145 mg | Not calculated |
| Beta vulgaris Source : Racine Extract : Matériel brut sec Potency : 0 Ratio: 10-15:1 QCE: 1450-2175 mg | Not specified | Not calculated |
| Thiamine Source : Benfotiamine | 4.17 mg | 25,020 µg |
| 5-[(1E)-2-(4-hydroxyphényl)éthényl]-1,3-benzènediol | 16.67 mg | Not calculated |
| Acide 1H-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylique, 4,5-dihydro-4,5-dioxo- | 3.33 mg | Not calculated |
| Acide 2-oxobutanedioïque | 16.67 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Acide citrique, Stéaryl fumarate de sodium, Silice, Maltodextrine, Palmitate d'ascorbyle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 3 days |
Uses authorised in Canada
Provides antioxidants. Support nitric oxide levels; and helps with normal growth and energy production; to support cognitive health and/or brain function. Helps to maintain and/or support cardiovascular health. Acetyl-L-Carnitine helps temporarily reduce fatigue and helps to relieve pain associated with diabetic neuropathy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, do not use. If you have liver disease, kidney disease and/or a seizure disorder, consult a healthcare practitioner prior to use. If you are taking prescription medication, consult a healthcare practitioner prior to use as resveratrol may alter the effectiveness of these medications. Consult a healthcare practitioner prior to use if you are taking blood pressure medication or blood thinners. Consult a healthcare practitioner if migraine frequency increases, and associated nausea and vomiting persist or worsen. Consult a health care practitioner before use if you have diabetes. Discontinue use and consult a health care practitioner if you experience symptoms of hypoglycemia including feelings of anxiety, dizziness, tremor, sweating, nausea or headache. Consult a heath care practitioner prior to use if you are following a diet rich in nitrates (e.g plant from the Amaranthaceae family such as beets, spinach, etc.). Consult a heath care practitioner prior to use if you suffer from cardiovascular disease. If you have high cholesterol, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have been instructed to follow a low protein diet. Feelings of over stimulation and/or sleeplessness may occur, in which case discontinue use if feelings persist or worsen. Low incidences of seizures have been reported with oral doses in individuals with or without pre-existing seizure disorder. Body odor, flatulence, increased appetite and rash may occur. If the following symptoms appear: weakness, confusion, headache, difficulty breathing and/or pale, gray or blue colored skin, stop use and consult a healthcare practitioner. These symptoms may be signs of methemoglobinemia, a rare disorder, which may appear up to 2 hours after use. If you have Parkinson¿s Disease, do not use. Consult a health care practitioner for use beyond 3 weeks.
- Effets indésirables connus
May cause digestive problems. May cause cold, abdominal symptoms, headache, fatigue (fatigability) and diarrhea.
Source
Official Health Canada record, licence 80088927
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.